Aileron Therapeutics (ALRN) Tops Q1 EPS by 16c

Aileron Therapeutics (NASDAQ: ALRN) reported Q1 EPS of ($0.86), $0.16 better than the analyst estimate of ($1.02).

For earnings history and earnings-related data on Aileron Therapeutics (alrn) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
• SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds